Session

PP 05 IBD (Posters)

BENEFICIAL EFFECT OF INTESTINAL ALKALINE PHOSPHATASE IN THE MECHANISM OF MODULATION OF THE GENE EXPRESSION OF PROINFLAMMATORY BIOMARKERS IN THE ADIPOSE TISSUE, LIVER AND SKELETAL MUSCLE OF TREADMILL EXERCISING OBESE MICE WITH COLITIS
BENEFICIAL EFFECT OF INTESTINAL ALKALINE PHOSPHATASE IN THE MECHANISM OF MODULATION OF THE GENE EXPRESSION OF PROINFLAMMATORY BIOMARKERS IN THE ADIPOSE TISSUE, LIVER AND SKELETAL MUSCLE OF TREADMILL EXERCISING OBESE MICE WITH COLITIS

DISAGREEMENT BETWEEN ENDOSCOPIC AND TRANSMURAL HEALING IN CROHN’S DISEASE AND THE IMPACT OF DISEASE DURATION
DISAGREEMENT BETWEEN ENDOSCOPIC AND TRANSMURAL HEALING IN CROHN’S DISEASE AND THE IMPACT OF DISEASE DURATION

A LOW FAT, HIGH FIBER DIETARY INTERVENTION LEADS TO CHANGES IN SERUM PROTEOMIC PATTERNS IN CROHN’S DISEASE PATIENTS COMPARED TO HOUSEHOLD CONTROLS
A LOW FAT, HIGH FIBER DIETARY INTERVENTION LEADS TO CHANGES IN SERUM PROTEOMIC PATTERNS IN CROHN’S DISEASE PATIENTS COMPARED TO HOUSEHOLD CONTROLS

NOVEL DIGITAL HEALTH TOOLS IMPROVE CLINICAL OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: PRELIMINARY RESULTS
NOVEL DIGITAL HEALTH TOOLS IMPROVE CLINICAL OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: PRELIMINARY RESULTS

EFFECTIVENESS, SAFETY AND INCREMENTAL COSTS OF PROACTIVE THERAPEUTIC DRUG MONITORING OF INFLIXIMAB IN A REAL-LIFE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS
EFFECTIVENESS, SAFETY AND INCREMENTAL COSTS OF PROACTIVE THERAPEUTIC DRUG MONITORING OF INFLIXIMAB IN A REAL-LIFE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS

CORRELATION BETWEEN SERUM ANTI-TNF TROUGH CONCENTRATIONS AND TRANSMURAL DAMAGE IN CROHN’S DISEASE PATIENTS IN LONG STANDING AND STABLE CLINICAL REMISSION
CORRELATION BETWEEN SERUM ANTI-TNF TROUGH CONCENTRATIONS AND TRANSMURAL DAMAGE IN CROHN’S DISEASE PATIENTS IN LONG STANDING AND STABLE CLINICAL REMISSION

MANAGEMENT OF METASTATIC CUTANEOUS CROHN´S DISEASE USING USTEKINUMAB: A SINGLE CENTRE STUDY
MANAGEMENT OF METASTATIC CUTANEOUS CROHN´S DISEASE USING USTEKINUMAB: A SINGLE CENTRE STUDY

ULCERATIVE COLITIS – CROHN´S DISEASE CONVERSION RATE IN THE COHORT OF PATIENTS WITH ULCERATIVE COLITIS UNDERGOING COLECTOMY
ULCERATIVE COLITIS – CROHN´S DISEASE CONVERSION RATE IN THE COHORT OF PATIENTS WITH ULCERATIVE COLITIS UNDERGOING COLECTOMY

IMPACT OF VITAMINS, PROBIOTICS, ANTIBIOTICS, AND THE HISTORY OF COVID-19 INFECTION ON THE GUT MICROBIOME IN ULCERATIVE COLITIS PATIENTS
IMPACT OF VITAMINS, PROBIOTICS, ANTIBIOTICS, AND THE HISTORY OF COVID-19 INFECTION ON THE GUT MICROBIOME IN ULCERATIVE COLITIS PATIENTS

THIOPURINES IN CROHN'S DISEASE: DO THEY STILL HAVE A PLACE AS MONOTHERAPY IN REAL LIFE?
THIOPURINES IN CROHN'S DISEASE: DO THEY STILL HAVE A PLACE AS MONOTHERAPY IN REAL LIFE?

ENDOSCOPIC BALLOON DILATATION ASSOCIATED WITH BIOLOGICAL THERAPY IN CROHN’S DISEASE STRICTURES: A SINGLE CENTER EXPERIENCE
ENDOSCOPIC BALLOON DILATATION ASSOCIATED WITH BIOLOGICAL THERAPY IN CROHN’S DISEASE STRICTURES: A SINGLE CENTER EXPERIENCE

USTEKINUMAB TREATMENT IN CROHN’S DISEASE AND ULCERATIVE COLITIS: A REAL-WORLD COMPARISON BETWEEN ITS EFFECTIVENESS AND SAFETY IN THIS TWO POPULATIONS
USTEKINUMAB TREATMENT IN CROHN’S DISEASE AND ULCERATIVE COLITIS: A REAL-WORLD COMPARISON BETWEEN ITS EFFECTIVENESS AND SAFETY IN THIS TWO POPULATIONS

INFLAMMATORY BOWEL DISEASE WITH CONCOMITANT ENDOMETRIOSIS: CHARACTERIZATION AND 1-YEAR CLINICAL OUTCOME IN A PROSPECTIVE STUDY
INFLAMMATORY BOWEL DISEASE WITH CONCOMITANT ENDOMETRIOSIS: CHARACTERIZATION AND 1-YEAR CLINICAL OUTCOME IN A PROSPECTIVE STUDY

THE VALUE OF QUANTIFERON IN THE DIFFERENTIAL DIAGNOSIS OF CROHN'S DISEASE AND INTESTINAL TUBERCULOSIS
THE VALUE OF QUANTIFERON IN THE DIFFERENTIAL DIAGNOSIS OF CROHN'S DISEASE AND INTESTINAL TUBERCULOSIS

THE EFFECT OF COMMONLY PRESCRIBED MEDICATIONS ON THE TRANSCRIPTOME OF PATIENTS SUFFERING FROM IBD AND OTHER CHRONIC INFLAMMATORY DISEASES
THE EFFECT OF COMMONLY PRESCRIBED MEDICATIONS ON THE TRANSCRIPTOME OF PATIENTS SUFFERING FROM IBD AND OTHER CHRONIC INFLAMMATORY DISEASES

RISK FACTORS FOR INTESTINAL AND EXTRA-INTESTINAL CANCERS IN INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE MONOCENTRIC COHORT STUDY
RISK FACTORS FOR INTESTINAL AND EXTRA-INTESTINAL CANCERS IN INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE MONOCENTRIC COHORT STUDY

PREVALENCE OF GASTROINTESTINAL SYMPTOMS, QUALITY OF LIFE, VISCERAL HYPERSENSITIVITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN DEEP REMISSION
PREVALENCE OF GASTROINTESTINAL SYMPTOMS, QUALITY OF LIFE, VISCERAL HYPERSENSITIVITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN DEEP REMISSION

RISK FACTORS OF MICROSCOPIC COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
RISK FACTORS OF MICROSCOPIC COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS

EFFECTS OF AN EXCLUSION DIET ON INFLAMMATION MARKERS AND MAINTENANCE OF REMISSION IN PATIENTS WITH QUIESCENT IBD – A 1-YEAR PROSPECTIVE TRIAL
EFFECTS OF AN EXCLUSION DIET ON INFLAMMATION MARKERS AND MAINTENANCE OF REMISSION IN PATIENTS WITH QUIESCENT IBD – A 1-YEAR PROSPECTIVE TRIAL

ENTERIC INFECTIONS WORSEN POST DISCHARGE OUTCOMES IN PATIENTS HOSPITALIZED FOR INFLAMMATORY BOWEL DISEASE FLARE: A SINGLE CENTER STUDY.
ENTERIC INFECTIONS WORSEN POST DISCHARGE OUTCOMES IN PATIENTS HOSPITALIZED FOR INFLAMMATORY BOWEL DISEASE FLARE: A SINGLE CENTER STUDY.

Item 421 - 440 / 826
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
22
23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42